MD has 36-month beta value of 1.57. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for MD is 84.70M, and currently, short sellers hold a 2.73% ratio of that float. The average trading volume of MD on January 20, 2025 was 719.93K shares.
MD) stock’s latest price update
The stock of Pediatrix Medical Group Inc (NYSE: MD) has increased by 0.51 when compared to last closing price of 13.77. Despite this, the company has experienced a 11.25% gain in its stock price over the last five trading sessions. zacks.com reported 2025-01-13 that Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
MD’s Market Performance
Pediatrix Medical Group Inc (MD) has seen a 11.25% rise in stock performance for the week, with a -4.22% decline in the past month and a 9.32% surge in the past quarter. The volatility ratio for the week is 3.26%, and the volatility levels for the past 30 days are at 3.35% for MD. The simple moving average for the past 20 days is 3.09% for MD’s stock, with a 29.70% simple moving average for the past 200 days.
Analysts’ Opinion of MD
Jefferies, on the other hand, stated in their research note that they expect to see MD reach a price target of $14, previously predicting the price at $8. The rating they have provided for MD stocks is “Buy” according to the report published on September 26th, 2024.
Deutsche Bank gave a rating of “Hold” to MD, setting the target price at $8 in the report published on June 07th of the previous year.
MD Trading at -3.08% from the 50-Day Moving Average
After a stumble in the market that brought MD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.66% of loss for the given period.
Volatility was left at 3.35%, however, over the last 30 days, the volatility rate increased by 3.26%, as shares sank -2.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.59% lower at present.
During the last 5 trading sessions, MD rose by +11.25%, which changed the moving average for the period of 200-days by +45.68% in comparison to the 20-day moving average, which settled at $13.43. In addition, Pediatrix Medical Group Inc saw 5.49% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MD starting from ORDAN MARK S, who sale 27,600 shares at the price of $15.35 back on Nov 13 ’24. After this action, ORDAN MARK S now owns 138,683 shares of Pediatrix Medical Group Inc, valued at $423,660 using the latest closing price.
ORDAN MARK S, the Director of Pediatrix Medical Group Inc, proposed sale 27,600 shares at $15.50 during a trade that took place back on Nov 13 ’24, which means that ORDAN MARK S is holding shares at $427,800 based on the most recent closing price.
Stock Fundamentals for MD
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.2 for the gross margin
The net margin for Pediatrix Medical Group Inc stands at -0.13. The total capital return value is set at -0.0. Equity return is now at value -29.85, with -11.53 for asset returns.
Based on Pediatrix Medical Group Inc (MD), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.93. The interest coverage ratio of the stock is -0.11.
Currently, EBITDA for the company is 29.89 million with net debt to EBITDA at -3.02. When we switch over and look at the enterprise to sales, we see a ratio of 0.88. The receivables turnover for the company is 6.97for trailing twelve months and the total asset turnover is 0.97. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.42.
Conclusion
To put it simply, Pediatrix Medical Group Inc (MD) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
